BRIEF-FDA approves Amgen's Amjevita (Adalimumab-Atto) By: Reuters: Company News September 23, 2016 at 18:19 PM EDT * Amgen Inc says Amjevita is Amgen's first biosimilar to receive regulatory approval Read More >> Related Stocks: Amgen